Cargando…
Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy”
Autores principales: | Fitzgerald, Bryna L., Islam, M. Nurul, Graham, Barbara, Mahapatra, Sebabrata, Webb, Kristofor, Boom, W. Henry, Malherbe, Stephanus T., Joloba, Moses L., Johnson, John L., Winter, Jill, Walzl, Gerhard, Belisle, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580363/ https://www.ncbi.nlm.nih.gov/pubmed/30864780 http://dx.doi.org/10.1021/acsinfecdis.9b00068 |
Ejemplares similares
-
Elucidation of a Human Urine Metabolite as a Seryl-Leucine
Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy
por: Fitzgerald, Bryna L., et al.
Publicado: (2018) -
Elucidating the Structure of N(1)-Acetylisoputreanine:
A Novel Polyamine Catabolite
in Human Urine
por: Fitzgerald, Bryna L., et al.
Publicado: (2017) -
A metabolic biosignature of early response to anti-tuberculosis treatment
por: Mahapatra, Sebabrata, et al.
Publicado: (2014) -
Identification of Urine Metabolites as Biomarkers of Early Lyme Disease
por: Pegalajar-Jurado, Adoracion, et al.
Publicado: (2018) -
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome
por: Silva, Carlos A.M., et al.
Publicado: (2019)